ARTICLE | Clinical News
Amoxicillin Pulsys fails second Phase III
July 22, 2005 1:11 AM UTC
Advancis (AVNC) and Par (PRX) said Amoxicillin Pulsys missed the primary endpoint in a pediatric Phase III trial to treat pharyngitis/tonsillitis due to Group A streptococcal infections. The primary e...